Non-interventional Study of Long-term Intrauterine Contraceptives Acceptability and User Satisfaction

CompletedOBSERVATIONAL
Enrollment

2,348

Participants

Timeline

Start Date

September 30, 2011

Primary Completion Date

March 31, 2014

Study Completion Date

October 31, 2014

Conditions
Contraception
Interventions
DRUG

Levonorgestrel (Mirena, BAY86-5028)

intrauterine system containing 52 mg levonorgestrel, with daily release of 20 mcg levonorgestrel

DEVICE

Copper IUD

Copper device, inserted intrauterine

Trial Locations (1)

Unknown

Many Locations

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Bayer

INDUSTRY